Vaginal Microbicide Preferences Among Midwestern Urban Adolescent Women

Journal of Adolescent Health

Volumn 43, Issue 4, 2008, Pages 349-356

  Tanner, Amanda E ^a   Katzenstein, Jennifer M ^b   Zimet, Gregory D ^a   Cox, Dena S ^b   Cox, Anthony D ^b   Fortenberry, J Dennis ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Adolescent women; Conjoint analysis; Microbicides; Sexuality

Indexed keywords

MICROBICIDE;

ADOLESCENT; ADOLESCENT PREGNANCY; ADULT; ARTICLE; CONTRACEPTION; DRUG CHOICE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UNSPECIFIED SIDE EFFECT; URBAN AREA;

ADOLESCENT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS, LOCAL; ATTITUDE TO HEALTH; CONTRACEPTION, POSTCOITAL; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MIDWESTERN UNITED STATES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SPERMATOCIDAL AGENTS; URBAN HEALTH; YOUNG ADULT;

EID: 52049108927     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2008.02.017     Document Type: Article

References (40)

1. Alliance for Microbicide Development. Ongoing microbicide clinical trials by phase. http://secure.microbicide.org/NetReports/Clinical TrialsOngoingByPhase.aspx Accessed January 25, 2007
2. Harrison P., Rosenberg Z., and Bowcut J. Topical microbicides for disease prevention: status and challenges. Clin Infect Dis 36 (2003) 1290-1294
3. Rosenbaum L., Sanford W., and Jacobs J.Z. Sexuality. The Boston Women's Book Collective, Our bodies, Ourselves for the New Century (1998), Simon & Schuster Inc, New York 229-267
4. Diamond L.M. Introduction: in search of good sexual-development pathways for adolescent girls. New Dir Child Adolesc Dev 112 (2006) 1-7
5. Farr G., Gabelnick H., Sturgen K., et al. Contraceptive efficacy and acceptability of the female condom. Am J Public Health 84 12 (1994) 1960-1964
6. Kaler A. The female condom in North America: selling the technology of "empowerment.". J Gender Stud 13 2 (2004) 139-152
7. Short M.B., Mills L., Majkowski J.M., et al. Adolescent issues associated with knowledge of and access to topical microbicides. J Womens Health 13 10 (2004) 1127-1135
8. Holt B., Morwitz V.G., Ngo L., et al. Microbicide preference among young women in California. J Womens Health 15 3 (2006) 281-294
9. Zubowicz E.A., Oakes J.K., Short M.B., et al. Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use. J Womens Health 15 8 (2006) 952-961
10. Tanner AE, Zimet GD, Fortenberry JD, et al. Young women's use of a microbicide surrogate: the role of individual and contextual factors in acceptability and sexual pleasure. J Sex Res (In press).
11. Short M.B., Mills L., Majkowski J.M., et al. Topical microbicide use by adolescent girls: concerns about timing, efficacy, and safety. Sex Transm Dis 30 11 (2003) 854-858
12. Elias C., and Coggins C. Acceptability research on female controlled barrier methods to prevent heterosexual transmission of HIV: where have we been?. Where are we going?. J Womens Health 10 2 (2001) 163-173
13. Koo H., Woodsong C., Dalberth B., et al. Context of acceptability of topical microbicides: sexual relationships. J Soc Issues 61 1 (2005) 67-93
14. Mantell J., Myer L., Carballo-Dieguez A., et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med 60 (2005) 319-330
15. Sunder P.K., Ramos S., Short M.B., et al. Adolescent girls' communication with "mothers" about topical microbicides. J Pediatr Adolesc Gynecol 19 (2006) 373-379
16. Weeks M.R., Mosack K.E., Abbot M., et al. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention. Sex Transm Dis 31 11 (2004) 682-690
17. Bentley M., Fullem A., Tolley E., et al. Acceptability of a microbicide among women and their partners in a four country phase I trial. Am J Public Health 94 7 (2004) 1159-1165
18. Bancroft J. Researching Sexual Behavior (1997), Indiana University Press, Bloomington, IN
19. Richman W.L., Kiesler S., Weisband S., et al. A meta-analytic study of social desirability distortion in computer administered questionnaires, traditional questionnaires, and interviews. J Appl Psychol 84 5 (1999) 754-775
20. Kissinger P., Rice J., Farley T., et al. Application of computer-assisted interviews to sexual behavior research. Am J Epidemiol 149 10 (1999) 950-954
21. Kann L., Brener N.D., Warren C.W., et al. An assessment of the effect of data collection setting on the prevalence of health risk behaviors among adolescents. J Adolesc Health 31 4 (2002) 327-335
22. Turner C.F., Ku L., Rogers S.M., et al. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science 280 5365 (1998) 867-873
23. Severy L.J., and Newcomer S. Critical issues in contraceptive and STI acceptability research. J Soc Issues 61 1 (2005) 45-65
24. Woodsong C., and Severy L.J. Generation of knowledge for reproductive health technologies: constraints on social and behavioral research. J Soc Issues 61 1 (2005) 193-205
25. Indiana HIV Resources & Statistics. 2004. http://aids.about.com/od/statebystateresources/qt/indiana.htm Accessed January 28, 2007
26. Zimet G.D., Cox A.D., Cox D.S., and Fortenberry J.D. Vaginal microbicides for STD prevention: characteristics preferred by adolescent women [Abstract]. J Adolesc Health 36 2 (2005) 125
27. Campbell B.A. Race-of-interviewer effects among Southern adolescents. Public Opin Q 45 2 (1981) 231-244
28. Johns Hopkins Bloomberg School of Public Health. The INFO Project. Assuring access is essential. http://www.infoforhealth.org/inforeports/microbicides/microbs5.shtml Accessed January 10, 2008
29. SPSS Inc. SPSS Conjoint (2006), SPSS Inc, Chicago, IL
30. Green P., and Srinivasan V. Conjoint analysis in marketing: new developments with implications for research and practice. J Market (1990) 54-57
31. Churchill G.A. Marketing Research: Methodological Foundations. 5th ed. (1991), Dryden Press, Chicago, IL
32. Green P.E., and Rao V.R. Conjoint measurement for quantifying judgmental data. J Marketing Res 8 3 (1971) 355-363
33. Phillips K.A., Maddala T., and Johnson F.R. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res 3 (2002) 1681-1705
34. Ryan M., and Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 320 (2000) 1530-1533
35. Ryan M., and Hughes J. Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ 6 (1997) 261-273
36. Zimet G.D., Blythe M.J., and Fortenberry J.D. Vaccine characteristics and acceptability of HIV immunization among adolescents. Int J STD AIDS 11 (2000) 143-149
37. Zimet G.D., Mays R.M., Sturm L.A., et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 159 (2000) 132-137
38. Workowski K.A., and Levine W.C. Sexually transmitted treatment guidelines 2002. MMWR 51 RR06 (2002) 1-80
39. Center for Disease Control and Prevention. Adolescents and Young Adults. STD Surveillance 2005. http://www.cdc.gov/std/stats/adol.htm Accessed December 12, 2006
40. Armitage C.J., and Connor M. Efficacy of the theory of planned behavior: a meta-analytic review. Br J Soc Psychol 40 (2001) 471-499